Last reviewed · How we verify

NCT05302453

The Effect of Basic Body Awareness Therapy on Musculoskeletal Disorders and Psychological Symptoms

Completed NA Last updated 14 February 2023
What this trial tests

NA trial testing Basic Body Awareness Therapy in University Students in 60 participants. Completed in 1 October 2022.

Timeline
11 March 2021
Primary endpoint
11 June 2021
1 October 2022

Quick facts

Lead sponsorBandırma Onyedi Eylül University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment60
Start date11 March 2021
Primary completion11 June 2021
Estimated completion1 October 2022
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Bandırma Onyedi Eylül University

Who can join

Adults 18 to 25, any sex, with University Students. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

During the coronavirus disease (COVID-19) pandemic, stay-at-home isolation as a precaution to alleviate the disease has affected the physical and mental well-being of individuals. University students spent time in front of the screen with online education and developed a sedentary lifestyle during the academic term. In this process, musculoskeletal disorders increased more in university students due to the increase in the use of laptop or computer, smartphone, and social media. The COVID-19 pandemic has caused psychological disorders as well as physical health problems. General population studies have shown that all forms of depression, anxiety, stress, sleep problems, and psychological distress are highly increased during this period. In a study conducted in Turkey, it was reported that students' negative well-being, anxiety, and physical inactivity significantly affected perceived stress during the COVID-19 pandemic, and students' mental health was at high risk. It has been stated that providing mental health supportive systems in students and encouraging physical activity regularly can reduce perceived stress levels. On the other hand, psychological interventions via video conferencing platforms have been proposed to promote mental health due to the limited and delayed face-to-face healthcare as a result of the COVID-19 pandemic. It has been stated that the use of telemedicine or e-health applications together with body-mind approaches such as yoga, tai chi, qigong may be beneficial in order to encourage physical activity and protect mental health in this critical period. Basic Body Awareness Therapy (BBAT), which is among the body-mind approaches, is also frequently used in the rehabilitation of patients with psychiatric disorders, pain, and chronic musculoskeletal system problems. Therefore, the aim of this study is to evaluate the effect of BBAT on musculoskeletal disorders and psychological symptoms in university students who participated in the hybrid (online + face-to-face) education program during the COVID-19 pandemic. The importance of this study is that it is the first study on physical and psychological symptoms of BBAT in university students.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Effects of basic body awareness therapy via hybrid telerehabilitation on musculoskeletal and psychological symptoms in university students: A single-blind randomized controlled trial.
    Yuce H, Kecelioglu S, Akcay B, Yilmaz FN. · · 2026 · PMID 40997245 · DOI 10.1177/10538127251378088

Verify or expand the search:

Other trials of Basic Body Awareness Therapy

Trials testing the same drug.

Other recruiting trials for University Students

Currently open trials in the same condition.

Other Bandırma Onyedi Eylül University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05302453.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing